• Return to Headlines

Shares of Becton Dickinson Rise to a New 52-Week High

By David Diaz

Shares of Becton Dickinson (NYSE:BDX) traded at a new 52-week high today of $196.59. Approximately 229,000 shares have changed hands today, as compared to an average 30-day volume of 885,000 shares.

Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture, and sale of medical devices, instrument systems, and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public.

Becton Dickinson share prices have moved between a 52-week high of $196.59 and a 52-week low of $161.29 and are now trading 22% above that low price at $195.98 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.8%.

Becton Dickinson has overhead space with shares priced $195.98, or 2.6% below the average consensus analyst price target of $201.31. Becton Dickinson shares have support at the 50-day moving average (MA) of $153.96 and additional support at the 200-day MA of $147.03.

SmarTrend recommended that subscribers consider buying shares of Becton Dickinson on January 10th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $170.63. Since that recommendation, shares of Becton Dickinson have risen 13.2%. We continue to monitor BDX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows becton dickinson

Ticker(s): BDX